Once requiring years for overseas pharmaceuticals to enter the Chinese market, the Boao Lecheng International Medical Tourism Pilot Zone in Hainan has slashed the average approval timeline for globally advanced medical products to just 1.6 days. As China's only "medical special zone," Lecheng has already introduced over 500 innovative medicines and medical devices that are approved abroad but not yet available domestically.
Capitalizing on the unique policy advantages of the Hainan Free Trade Port, the pilot zone has established strategic partnerships with more than 180 pharmaceutical and medical device companies across 20 countries and regions.
A recent highlight was the International Health Consumption Zone, a sub-venue of the 6th China International Consumer Products Expo (CICPE) currently underway in Lecheng medical pilot zone in Boao, southern China's Hainan Province. The 25,000-square-meter exhibition space featured more than 340 international brands showcasing over 1,300 cutting-edge products.
To further streamline regulatory processes and accelerate patient access to life-saving treatments, Hainan authorities recently rolled out an expedited pre-approval policy. This initiative prioritizes innovative drugs and devices targeting rare diseases and serious, life-threatening conditions, ensuring that critical medical breakthroughs reach those in need faster than ever before.
CHOOSE YOUR LANGUAGE
互联网新闻信息许可证10120180008
Disinformation report hotline: 010-85061466